Olvi Oyj A (OLVAS)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 27.50 |
|---|---|
| 52-week range | 26.65 – 35.50 |
| Return, 1 month / 3 months | −14.3% / −14.6% |
| Return, 1 year / 3 years | −0.4% / +10.1% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 20.6% |
| Worst drawdown (1 year) | -19.7% |
| Average daily value traded | 0.31M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Olvi Oyj is a Finnish beverage company based in Iisalmi that brews beer and makes cider, long drinks, soft drinks, juices and bottled water. It serves retail shops, restaurants and other outlets through its own brands and contract production, and it operates in Finland and the Baltic countries as well as in Belarus. The company also produces and packages drinks for other brands alongside its own product lines.
The shares are listed on the Helsinki Exchange in Finland under the code OLVAS, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Olvi Oyj A (OLVAS) trades on the Helsinki Exchange in Finland. It last closed at EUR 27.50 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 76 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.4% and over the last three months it fell 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.8% | ||
| From 52-week high | -21.3% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.6% | ||
| 6-month return | -13.4% | ||
| 12-month return, skipping the last month | 16.3% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.7% | ||
| Liquidity | 70 · Strong | Trades actively. | |
| Average daily value traded | 0.31M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | −14.3% |
| 3 months | −14.6% |
| 6 months | −13.4% |
| 1 year | −0.4% |
| 3 years | +10.1% |
| 5 years | −35.4% |
Signals
| 50-day / 200-day average | 30.93 / 31.52 |
|---|---|
| Golden / death cross (60 days) | Death, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Sep 2026 | EUR 0.6800 |
| 2 Apr 2026 | EUR 0.6700 |
| 28 Aug 2025 | EUR 0.6500 |
| 17 Apr 2025 | EUR 0.6500 |
| 26 Aug 2024 | EUR 0.6000 |
| 27 Mar 2024 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.